Psychopharmacology

Scenario:

Jean Louis Pierre is a 20 year old business major at a large university. His family and friends have noticed increasingly bizarre behaviors over the past several months. On many occasions they’ve overheard him whispering in an agitated voice, even though there is no one nearby. Lately, he has refused to answer or make calls on his cell phone, claiming that if he does it will activate a deadly chip that was implanted in his brain by Vodou priests.

Based on this scenario, respond to the following prompts:

Which condition does the psychiatric NP associate with these patient behaviors? What do you know about the etiology of this disorder?
What are positive symptoms of schizophrenia? What are negative symptoms of schizophrenia? What is the difference between Brief Psychotic Disorder, Schizophreniform, and Schizoaffective disorder?
What treatment options will you offer this patient and why? (Provide non-pharmacological and pharmacological interventions, including nursing interventions as well as cultural considerations among Haitian populations with psychiatric conditions)
What do you know about the mechanism of action of anti-psychotic medications? What labs should you order prior to or during the course of treatment for patients on this class of medication and why? What is the metabolic syndrome and how is it relevant to this case?

Full Answer Section

         
    • Copy Number Variations (CNVs): Large deletions or duplications of DNA segments are also implicated, often leading to a higher risk of schizophrenia or other neurodevelopmental disorders.
  • Neurobiological Factors (Brain Structure and Function):

    • Neurotransmitter Dysregulation:
      • Dopamine Hypothesis: The classical theory suggests an excess of dopamine activity in certain brain regions (mesolimbic pathway), leading to positive symptoms, and a deficit of dopamine in other regions (mesocortical pathway), contributing to negative symptoms and cognitive impairment.
      • Glutamate Hypothesis: More recent theories emphasize dysfunction in glutamate pathways, particularly involving NMDA receptors. Hypofunction of NMDA receptors may lead to increased dopamine release and contribute to both positive and negative symptoms.
      • Other Neurotransmitters: Serotonin, GABA, and acetylcholine also play roles in the complex neurocircuitry affected in schizophrenia.
    • Brain Structural Abnormalities: While not consistently present in all individuals, common findings include:
      • Enlarged ventricles (fluid-filled spaces in the brain).
      • Reduced gray matter volume, particularly in the prefrontal cortex, temporal lobes, and hippocampus.
      • Abnormalities in white matter tracts, affecting neural connectivity.
    • Brain Functional Abnormalities: Impaired connectivity and dysfunctional neural networks, especially those involved in executive function, attention, and processing of sensory information.
  • Environmental Factors: These factors interact with genetic predispositions to increase risk, often acting as "stressors" or "triggers" during critical periods of brain development.

    • Perinatal Complications: Obstetric complications such as prenatal exposure to infection (e.g., influenza, toxoplasmosis), severe maternal stress, malnutrition during pregnancy, birth complications (e.g., hypoxia), and low birth weight.
    • Childhood Trauma/Adversity: Exposure to severe early-life trauma, abuse, or neglect.
    • Urban Living: Growing up in urban environments is associated with a higher risk, possibly due to increased stress, social fragmentation, or exposure to pollutants.
    • Substance Use: Cannabis use (especially high-potency varieties and early onset use) is a significant risk factor, particularly in genetically vulnerable individuals. Other substance abuse can also trigger or worsen symptoms.
    • Social Stressors: Migration, discrimination, and social isolation.

In Jean Louis Pierre's case, as a 20-year-old, he is within the typical age of onset for schizophrenia (late teens to mid-20s for males). The Vodou priests and deadly chip delusion highlights a culturally influenced paranoid delusion, which is common in schizophrenia. His whispering in an agitated voice suggests auditory hallucinations (hearing voices), another hallmark positive symptom.


2. Positive & Negative Symptoms and Differential Diagnoses

Positive Symptoms of Schizophrenia:

These are "additions" to a person's normal experiences and are often the most overt and dramatic. They reflect a distortion of normal mental functions.

  • Delusions: Fixed, false beliefs that are not amenable to change in light of conflicting evidence. They can be persecutory (e.g., "deadly chip implanted by Vodou priests" – as in Jean Louis Pierre's case), grandiose, referential (belief that environmental cues are directed at oneself), somatic, or nihilistic.

Sample Answer

       

Given the scenario of Jean Louis Pierre, a 20-year-old business major exhibiting increasingly bizarre behaviors over several months, including auditory hallucinations and a complex delusion about a "deadly chip implanted by Vodou priests," here's how a psychiatric Nurse Practitioner (NP) would approach this case.


1. Condition Associated with Patient Behaviors & Etiology

The psychiatric NP would most strongly associate these behaviors with Schizophrenia Spectrum Disorder, particularly considering the duration (several months) and the nature of the symptoms (hallucinations, delusions). Given his age, it's likely a first-episode psychosis that points towards this spectrum.

Etiology of Schizophrenia Spectrum Disorder:

Schizophrenia is a complex neurodevelopmental disorder with a multifactorial etiology, meaning it arises from a combination of genetic, neurobiological, and environmental factors.

  • Genetic Factors:

    • Heritability: Schizophrenia is highly heritable, with genetic factors accounting for about 80% of the risk. It's not a single gene, but rather a polygenic disorder, meaning many genes with small effects contribute to the overall risk.
    • Specific Genes: While no single gene causes schizophrenia, research has identified numerous genes and gene variations (polymorphisms) that increase susceptibility. These include genes involved in neuronal development, synaptic plasticity, immune function, and neurotransmitter systems (e.g., DISC1, NRG1, COMT, genes within the Major Histocompatibility Complex - MHC).